Vadim Cherezov

Find an error

Name: Cherezov, Vadim
Organization: University of Southern California , USA
Department: Department of Chemistry
Title: (PhD)
Co-reporter:Linda C. Johansson, Benjamin Stauch, Andrii Ishchenko, Vadim Cherezov
Trends in Biochemical Sciences 2017 Volume 42, Issue 9(Issue 9) pp:
Publication Date(Web):1 September 2017
DOI:10.1016/j.tibs.2017.06.007
X-ray free electron lasers (XFELs) have the potential to revolutionize macromolecular structural biology due to the unique combination of spatial coherence, extreme peak brilliance, and short duration of X-ray pulses. A recently emerged serial femtosecond (fs) crystallography (SFX) approach using XFEL radiation overcomes some of the biggest hurdles of traditional crystallography related to radiation damage through the diffraction-before-destruction principle. Intense fs XFEL pulses enable high-resolution room-temperature structure determination of difficult-to-crystallize biological macromolecules, while simultaneously opening a new era of time-resolved structural studies. Here, we review the latest developments in instrumentation, sample delivery, data analysis, crystallization methods, and applications of SFX to important biological questions, and conclude with brief insights into the bright future of structural biology using XFELs.
Co-reporter:Andrii Ishchenko;Petr A. Popov;Ming-Yue Lee;Alexander Batyuk;Cornelius Gati;Benjamin Stauch;Lorenzo Galli;Andrew Aquila;Anton Barty;Gye Won Han;Thomas A. White;Mark S. Hunter;Sébastien Boutet;Yun Zhao;Vsevolod Katritch;Chufeng Li;Raymond C. Stevens;John C. H. Spence;Mengchen Pu;Wei Liu;Zhi-jie Liu;Daniel James;Garrett Nelson;Uwe Weierstall;Petra Fromme;Mengning Liang
Science Advances 2016 Volume 2(Issue 9) pp:e1600292
Publication Date(Web):23 Sep 2016
DOI:10.1126/sciadv.1600292

Anomalous signal from sulfur atoms present in most proteins was used for de novo phasing of XFEL data and solving a GPCR structure.

Adenosine5'-(trihydrogen diphosphate), 2-(methylthio)-
Angiotensin II
1,6-Naphthyridin-2(1H)-one,5,7-diethyl-3,4-dihydro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,hydrochloride (1:1)